CA 19-9 Levels Predict Results of Staging Laparoscopy in Pancreatic Cancer
- 5 December 2005
- journal article
- Published by Elsevier BV in Journal of Gastrointestinal Surgery
- Vol. 9 (9), 1286-1292
- https://doi.org/10.1016/j.gassur.2005.06.008
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by Computed TomographySurgical Endoscopy, 2005
- Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma?Journal of Gastrointestinal Surgery, 2004
- Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2004
- Laparoscopy in the staging of pancreatic cancerBritish Journal of Surgery, 2001
- Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundiceEuropean Journal of Surgical Oncology, 2000
- Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass11No competing interests declared.Journal of the American College of Surgeons, 1999
- Computed Tomography and Laparoscopy in the Assessment of the Patient With Pancreatic CancerJournal of the American College of Surgeons, 1998
- The Value of Minimal Access Surgery in the Staging of Patients with Potentially Resectable Peripancreatic MalignancyAnnals of Surgery, 1996
- Prognostic Value of Serum CA 19–9 Levels in Pancreatic AdenocarcinomaAnnals of Surgery, 1992
- Laparoscopy in the staging and planning of therapy for pancreatic cancerThe American Journal of Surgery, 1986